Berkan Karabuga
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
From the stands to survival fandom, a psychosocial force in the fight against cancer.
Journal: Journal of health psychology
Published: June 23, 2026
Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Current oncology (Toronto, Ont.)
Published: May 02, 2026
Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 26, 2026
Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 24, 2026
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 22, 2026
Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study.
Journal: In vivo (Athens, Greece)
Published: March 10, 2026
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.
Journal: Journal of clinical medicine
Published: February 01, 2026
A novel inflammation and tumor marker-based prognostic score, neutrophil-lymphocyte ratio-C-reactive protein-Ca19-9, in metastatic gastric cancer.
Journal: Oncology letters
Published: January 15, 2026
Large Language Models as Decision-support Tools for Adjuvant Therapy Planning in Early-stage Hormone Receptor-positive Breast Cancer.
Journal: Cancer diagnosis & prognosis
Published: January 12, 2026
Last Updated: 09/26/2026